A- A A+

Gesundheitsversorgung in Gefängnissen: Krank im Knast 

In deutschen Gefängnissen fehlt es an Geld, Personal und Medikamenten – mit teils dramatischen Folgen für die Häftlinge. (Die Tageszeitung, 04.08.2020)

Gesundheitsversorgung in Gefängnissen: Krank im Knast 

Risk factors for self-harm in prison: a systematic review and meta-analysis

Favril, Louis et al.

The Lancet Psychiatry, Volume 7, Issue 8, 682 - 691 


The Accessibility of Opioid Agonist Treatment and Its Forced Discontinuation in Swiss Prisons-Attitudes, Perceptions and Experiences of Defense Lawyers in Dealing With Detained Persons Using Opioids. 

Buadze A, Baggio S, Schleifer R, et al. 

Front Psychiatry. 2020;11:395. Published 2020 May 14. doi:10.3389/fpsyt.2020.00395


Prisoners should not be left behind in HCV research and policies. 

Moazen, B., Stöver, H., Dolan, K. et al. 

Harm Reduct J 17, 33 (2020). doi.org/10.1186/s12954-020-00379-y


Report. Global Prison Trends 2020

This year, PRI’s flagship publication Global Prison Trends, published alongside the Thailand Institute of Justice, has been released at a crucial time as prisons worldwide are being pushed to breaking point by the COVID-19 pandemic. Global Prison Trends 2020 documents the chronic issues that have led to this human rights and public health crisis and the challenges facing criminal justice systems in responding to the global pandemic. (PENAL REFORM INTERNATIONAL, UK, April 2020)


Implementation of opioid maintenance treatment in prisons in North Rhine-Westphalia, Germany - a top down approach.

Böhmer K, Schecke H, Render I, Scherbaum N.

Subst Abuse Treat Prev Policy. 2020 Mar 10;15(1):21. doi: 10.1186/s13011-020-00262-w.


Asistencial and therapeutic continuity after release from prison: an urgent problem that requires solutions. The model applied in Catalonian prisons.

Turu E, Barnés I, Marco A.

Rev Esp Sanid Penit. 2019;21(3):153-160.

PMID: 32083278


A study of the reasons for prescribing and misuse of gabapentinoids in prison including their co-prescription with opioids and antidepressants.

Soni A, Walters P.

Int J Prison Health. 2019 Aug 27;16(1):67-77. doi: 10.1108/IJPH-01-2019-0004.



Buprenorphin-Depot: Annäherung an das Äquivalenzprinzip in Haft - Besondere Eignung von Buvidal® zur Substitutionstherapie in der JVA 

Mannheim/Lund, 13.12.2019 – Die 4. Gefängnismedizintage am 5. und 6. Dezember 2019 in Frankfurt stießen auf reges Interesse bei Medizinern und Pflegekräften im Vollzug. Dem von der Camurus GmbH unterstützten Symposium „Das Depot – neue Wege in der Behandlung der Opioidabhängigkeit im Justizvollzug“ wohnten etwa 200 Besucher*innen bei. Mit der wachsenden Verfügbarkeit des Buprenorphin-Depots in Justizvollzugsanstalten kann eine deutliche Annäherung an das geforderte Äquivalenzprinzip erreicht werden, so ein Fazit der Referate und nachfolgenden Diskussion. (Camurus, Mannheim/Lund, 13.12.2019)


Gender and drug policy: Exploring global innovative approaches to drug policy and incarceration

Across the Americas, drug policies have failed to make a significant dent in the drug trade, while corruption and organized crime continue to thrive. At the same time, these harmful drug policies disproportionately fall on the most vulnerable, including poor women who often enter the drug trade because of desperation, lack of opportunity, and coercion. Stuck in a vicious cycle, the incarceration of these women only heightens their situation of vulnerability and takes a toll on their families and communities. (IDCP, UK, 2017-2020, Artikelserie)


Opioid-related treatment, interventions, and outcomes among incarcerated persons: A systematic review.

Malta M, Varatharajan T, Russell C, Pang M, Bonato S, Fischer B (2019) 

PLoS Med 16(12): e1003002. https://doi.org/10.1371/journal.pmed.1003002


Longitudinal analysis of HIV-risk behaviors of participants in a randomized trial of prison-initiated buprenorphine.

Blue TR, Gordon MS, Schwartz RP, Couvillion K, Vocci FJ, Fitzgerald TT, O'Grady KE.

Addict Sci Clin Pract. 2019 Dec 2;14(1):45. doi: 10.1186/s13722-019-0172-2.


Opioid substitution therapy for people living in German prisons—inequality compared with civic sector.

Stöver, H., Jamin, D., Michels, I.I. et al. 

Harm Reduct J 16, 72 (2019) doi:10.1186/s12954-019-0340-4


Freiburg/Brsg. "Wir schaffen das zusammen" 

Drei Insassen der Freiburger Justizvollzugsanstalt erzählen ihre Geschichten – über Methadon, Vatergefühle und Familienbesuche im Gefängnis. (Badische Zeitung, 20.12.2019)


Acceptability and efficacy of naltrexone for criminal justice‐involved individuals with opioid use disorder: a systematic review and meta‐analysis.

Bahji, A., Carlone, D., and Altomare, J. ( 2019) 

Addiction, doi.org/10.1111/add.14946.



USA. ‘First Shot is Free’: Hundreds Incarcerated in Michigan Offered Opioid Blocker Shots

The Michigan Department of Corrections says more than 20% of its inmates have an opioid-use disorder. Wayne County Jail, the state’s largest, has similar numbers. (AT Forum, USA, 19.12.2019)


UK. Report: Unlocking the evidence: Understanding suicide in prisons

People in prison are significantly more likely to die by suicide than people in the general population.

In 2018 alone, there were 92 self-inflicted deaths in prisons in England and Wales. At Samaritans, we see the enormous scale of emotional distress in prisons – last year alone we provided emotional support to people in prison more than 300,000 times. We also see the wide range of concerns that underpin their distress.

Our report, Unlocking the evidence: Understanding suicide in prisons, brings together data from the Samaritans service with analysis of the wider literature on suicide in prisons. The report deepens out understanding of the reasons behind the high rate of suicide in prisons. (Samaritans, UK, 2019)


Opioid Use Disorder Treatment Decision Making And Care Navigation Upon Release From Prison: A Feasibility Study.

Banta-Green CJ, Floyd AS, Vick K, Arthur J, Hoeft TJ, Tsui JI.

Subst Abuse Rehabil. 2019 Oct 22;10:57-67. doi: 10.2147/SAR.S192045. 


Europa. Status report on prison health in the WHO European Region. Copenhagen: WHO Regional Office for Europe; 2019. Licence: CC BY-NC-SA 3.0 IGO. 

Der Bericht enthält eine Analyse der erhobenen Daten zum Gesundheitsstatus von Häftlingen und den Gesundheitssystemen im Strafvollzug in 39 Ländern in der Europäischen Region der WHO.


Mehr Suizidfälle in deutschen Haftanstalten

Berlin – Die Zahl der Suizidfälle in deutschen Haftanstalten hat zugenommen. Wie aus einer Antwort der Bundesregierung auf eine Anfrage der Linksfraktion hervorgeht, star­ben 2017 im Justizvollzug 173 Menschen, 82 von ihnen durch Selbsttötung. So viele Sui­zide in der Haft hat es seit 2005 nicht gegeben. Für 2018 gibt es noch keine bundesweite Übersicht. (aerzteblatt.de, 25.11.2019)


Methadone treatment of arrestees: A randomized clinical trial.

Schwartz RP, Kelly SM, Mitchell SG, O'Grady KE, Sharma A, Jaffe JH.

Drug Alcohol Depend. 2019 Oct 28:107680. doi: 10.1016/j.drugalcdep.2019.107680. 


Opioidabhängige Menschen in Haft: Am unteren Ende der Hierarchie

Dtsch Arztebl 2019; 116(47): A-2182 / B-1786 / C-1744

Bühring, Petra

Suchtkranke Menschen werden in Justizvollzugsanstalten häufig nicht adäquat gesundheitlich versorgt. Insbesondere Heroinabhängige erhalten selten eine Substitutionsbehandlung. Die Initiative „Gesundheit in Haft“ von Suchtmedizinern und anderen Experten will ihre Situation verbessern.


Europa. New WHO report: Ignoring the health of people in prisons now comes at a high cost for society later

The “WHO status report on prison health in the WHO European Region” presents an analysis of data collected on the health status of people in prison and prison health systems for 39 countries in the Region. The WHO survey collected data from Member States between 2016 and 2017 to enable monitoring and surveillance of health in prisons. (WHO Office for Europe, Kopenhagen, 21.11.2019)


Substitutionsbehandlung in Haft - Erfahrungen in NRW

Prof. Dr. Norbert Scherbaum

Ärztlicher Direktor LVR-Klinikum Essen. Kliniken und Institut der Universität Duisburg-Essen, Klinik für Abhängiges Verhalten und Suchtmedizin, Klinik für Psychiatrie und Psychotherapie

5. Nationale Substitutionskonferenz (NaSuKo), 27.9.19 Berlin


Substitutionsbehandlung nach Haftentlassung

Frank Woike – Beauftragter für Sucht und Suchtprävention der Stadt Hannover

5.Nationale Substitutionskonferenz (NaSuKo), 27.9.19 Berlin


Substance use characteristics, health risk practices and associated factors among people imprisoned in Catalonia: a cross-sectional study.

Bañuls-Oncina E, Clua-García R, Imbernón Casas M, Jiménez-Vinaja R.

Rev Esp Sanid Penit. 2019;21(2):80-87. PMID: 31642858


Irland. Methadone usage at Cork Prison revealed 

ONE in seven inmates in Cork prison are on methadone.

According to figures released by Minister for Justice Charlie Flanagan, 41 inmates of the prison were on the drug on October 31.

There were 299 inmates in the prison on that date, meaning those on methadone represented 13.7% of the prison population. (echolive.ie, Irland, 09.11.2019)


USA. Mass. Has The First Jail In The Country That's Also A Licensed Methadone Treatment Provider

It's 7 a.m. in the library of the Franklin County Jail, and nurse Jennifer Maillet is preparing addiction medications for eight men.

She mixes methadone with water and crushes buprenorphine. She puts the medication in each man's mouth as correctional officers stand watch. Every five minutes, Maillet checks each mouth with a flashlight. After three checks the men are taken to a washroom to rinse their mouths, eat a Saltine cracker, rinse again, and wash their hands. (wbur.org, USA, 12.11.2019)


USA. Opioid Addiction In Jails: An Anthropologist's Perspective

Dr. Kimberly Sue is the medical director of the Harm Reduction Coalition, a national advocacy group that works to change U.S. policies and attitudes about the treatment of drug users. She's also a Harvard-trained anthropologist and a physician at the Rikers Island jail system in New York. (npr – National Public Radio, USA, 12.11.2019)


Clinician identified barriers to treatment for individuals in Appalachia with opioid use disorder following release from prison: a social ecological approach.

Bunting AM, Oser CB, Staton M, Eddens KS, Knudsen H.

Addict Sci Clin Pract. 2018 Dec 3;13(1):23. doi: 10.1186/s13722-018-0124-2.